Dr. Spandan Chennamadhavuni, PhD

Principal Scientist at Atea Pharmaceuticals, Inc
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Atlanta, Georgia, United States, GE
Languages
  • Telugu -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Akram Salam

Dr. Spandan was my team leader at the Emory Biotech Consulting Club (see link below). Our team of five consulted for Migra Therapeutics, a startup developing anti-cancer nanoparticles. We worked with Migra for five months to move their technology from preclinical to clinical studies and develop a scheme for company structure and funding. As our team leader, Dr. Spandan demonstrated admirable business development and interpersonal skills. Dr. Spandan from the beginning assessed our client's needs and outlined our deliverables. In managing his team, he trained us, organized regular meetings, made communication among the team very easy, was always positive and motivational, and agreed with each of us on regular deadlines for submitting our deliverables. At meetings with our client he presented our work with enthusiasm and addressed any changes to our client's needs. Our team was very diverse -- not only in personalities but in expertise -- and Dr. Spandan communicated effectively with everyone and on all topics: finance, regulatory, venture capital, pharmacology, and legal. After working with our client, Dr. Spandan stayed in touch with me and has been an amazing mentor. He has played a major role in helping me achieve my professional goals, and I am very grateful to him. I would be very excited to work with Dr. Spandan again! https://scholarblogs.emory.edu/ebcc/projects/program-projects-spring-2019/

khalid Ahsan

Dr. Spandan Chennamadhavuni worked as a TA in the Organic Chemistry Lab program at University at Buffalo. He has worked as a TA for CHE 201 (Fall 2005 and 2006), CHE 202 (Spring 2006 and 2007). A review of Spandan’s teaching evaluations indicates his popularity as a teaching assistant. As the organic lab coordinator who spends a lot of time working closely with teaching assistants, I would like to offer my observations of Spandan. I found him to be a hard working teaching assistant who was willing to assist his students in every possible way. He was always prepared for his recitations and appeared as someone who enjoyed teaching. I had a very good working relationship with Spandan; I would describe him as a true professional. I would place him among the top TA’s that have worked in our program. Spandan received "Mattern-Tyler Excellence in Teaching Award" in his first year as TA itself. It was given as a recognition of his exceptional competence in teaching sophomore organic chemistry to undergraduate students.

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Mighty Machines, Efficient Chemical Manufacturing enabled by Continuous Technology
    Scientific Update Ltd
    Jun, 2020
    - Nov, 2024
  • SciPhD Certificate Program
    SciPhD.com
    Sep, 2016
    - Nov, 2024
  • Emory University Nuclear Magnetic Resonance Center
    Emory University
    Jun, 2009
    - Nov, 2024

Experience

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Principal Scientist
      • Apr 2022 - Present

      Driving antiviral drug discovery programs. Driving antiviral drug discovery programs.

    • United States
    • Higher Education
    • 700 & Above Employee
    • Senior Staff Scientist
      • Sep 2015 - Apr 2022

      Design novel therapeutics targeting "​ ArmR" as potential antibacterial agents. Design novel therapeutics targeting "​ ArmR" as potential antibacterial agents.

    • Executive Committee Co-Chair
      • Sep 2015 - Aug 2017

      The Emory Postdoctoral Association (PDA), established in 2007, is an organization sponsored by the Emory School of Medicine (SOM) Office of Postdoctoral Education (OPE) and is dedicated to improving the postdoctoral experience for all fellows at Emory University. The executive committee provides leadership, organization, support, and continuity to the Postdoctoral Association (PDA). In formal settings, the co-chairs of the executive committee serve as the spokespersons on behalf of the PDA. The Emory Postdoctoral Association (PDA), established in 2007, is an organization sponsored by the Emory School of Medicine (SOM) Office of Postdoctoral Education (OPE) and is dedicated to improving the postdoctoral experience for all fellows at Emory University. The executive committee provides leadership, organization, support, and continuity to the Postdoctoral Association (PDA). In formal settings, the co-chairs of the executive committee serve as the spokespersons on behalf of the PDA.

    • United States
    • Higher Education
    • 700 & Above Employee
    • Research Scientist
      • Jun 2014 - Sep 2015

      MALT1 INHIBITORS FOR THE TREATMENT OF CHEMO-RESISTANT ABC-DLBCL MALT1 INHIBITORS FOR THE TREATMENT OF CHEMO-RESISTANT ABC-DLBCL

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Research Scientist
      • Jun 2014 - Sep 2015

      MALT1 INHIBITORS FOR THE TREATMENT OF CHEMO-RESISTANT ABC-DLBCL MALT1 INHIBITORS FOR THE TREATMENT OF CHEMO-RESISTANT ABC-DLBCL

    • United States
    • Higher Education
    • 700 & Above Employee
    • CMLD Research Associate
      • Oct 2011 - Jul 2014

      ➢ Design & synthesize chemical libraries of bioactive complex "natural product based" chemotypes ➢ Discover, develop & optimize novel chemical methodologies, build libraries around novel chemotypes ➢ Design and synthesis of novel macrocyclic scaffolds based on the computational docking results ➢ Analyzed the pharmacological data for orally available macrocyclic drugs for a “Nature Chemical Biology” review article ➢ re-synthesizing small molecule NEMO inhibitor discovered in high… Show more ➢ Design & synthesize chemical libraries of bioactive complex "natural product based" chemotypes ➢ Discover, develop & optimize novel chemical methodologies, build libraries around novel chemotypes ➢ Design and synthesis of novel macrocyclic scaffolds based on the computational docking results ➢ Analyzed the pharmacological data for orally available macrocyclic drugs for a “Nature Chemical Biology” review article ➢ re-synthesizing small molecule NEMO inhibitor discovered in high throughput screening of entire CMLD compound collection & establishing structure-activity relationship (SAR) around spiroisoxazoline core structure. ➢ Established a methodology for the synthesis of diazepinedione core by utilizing a three-step cascade (double bond isomerization/Aza-Michael/lactamization) reaction Show less ➢ Design & synthesize chemical libraries of bioactive complex "natural product based" chemotypes ➢ Discover, develop & optimize novel chemical methodologies, build libraries around novel chemotypes ➢ Design and synthesis of novel macrocyclic scaffolds based on the computational docking results ➢ Analyzed the pharmacological data for orally available macrocyclic drugs for a “Nature Chemical Biology” review article ➢ re-synthesizing small molecule NEMO inhibitor discovered in high… Show more ➢ Design & synthesize chemical libraries of bioactive complex "natural product based" chemotypes ➢ Discover, develop & optimize novel chemical methodologies, build libraries around novel chemotypes ➢ Design and synthesis of novel macrocyclic scaffolds based on the computational docking results ➢ Analyzed the pharmacological data for orally available macrocyclic drugs for a “Nature Chemical Biology” review article ➢ re-synthesizing small molecule NEMO inhibitor discovered in high throughput screening of entire CMLD compound collection & establishing structure-activity relationship (SAR) around spiroisoxazoline core structure. ➢ Established a methodology for the synthesis of diazepinedione core by utilizing a three-step cascade (double bond isomerization/Aza-Michael/lactamization) reaction Show less

    • United States
    • Higher Education
    • 700 & Above Employee
    • Graduate Research Assistant
      • Jul 2008 - Dec 2011

      SYNTHESIS OF SMALL MOLECULE THERAPEUTICS UTILIZING RHODIUM CARBENOID CHEMISTRY SYNTHESIS OF SMALL MOLECULE THERAPEUTICS UTILIZING RHODIUM CARBENOID CHEMISTRY

    • United States
    • Higher Education
    • 700 & Above Employee
    • Graduate Research Assistant
      • Aug 2006 - Aug 2008

      SYNTHESIS OF SMALL MOLECULE THERAPEUTICS UTILIZING RHODIUM CARBENOID CHEMISTRY SYNTHESIS OF SMALL MOLECULE THERAPEUTICS UTILIZING RHODIUM CARBENOID CHEMISTRY

    • United States
    • Higher Education
    • 700 & Above Employee
    • Graduate Research Assistant
      • Aug 2003 - Aug 2006

      "Brønsted Acid-Catalyzed Imine Amidation" published in JACs, Cited 165 times as of 2014 "Brønsted Acid-Catalyzed Imine Amidation" published in JACs, Cited 165 times as of 2014

Education

  • Emory University
    Doctor of Philosophy (PhD), Organic/ Medicinal Chemistry
    2006 - 2011
  • State University of New York at Buffalo
    Doctor of Philosophy (PhD) Continued at Emory, Organic Chemistry
    2006 - 2008
  • University of Mississippi
    Doctor of Philosophy (PhD) Discontinued, Organic Chemistry
    2003 - 2006
  • Osmania University
    Master of Science (M.Sc.), Organic Chemistry
  • Kakatiya University
    Bachelor of Science (B.Sc.), Organic Chemistry

Community

You need to have a working account to view this content. Click here to join now